Research into conolidine has brought about discovery of an opioid receptor in the human body known as ACKR3/CXCR7. ACKR3 appears to be by far the most wanted target for conolidine, which also disregards another four classical opioid receptors(3). This is rising to be a promising alternative drug. More importantly, https://walterr562kgu9.get-blogging.com/profile